ENTRY       D00509                      Drug
NAME        Phentolamine mesylate (USP);
            Phentolamine mesilate (JAN/INN);
            Regitine (TN)
PRODUCT     ORAVERSE (Septodont)
  GENERIC   PHENTOLAMINE MESYLATE (Precision Dose)
            PHENTOLAMINE MESYLATE (TAGI Pharma)
            PHENTOLAMINE MESYLATE (West-Ward Pharmaceuticals Corp)
FORMULA     C17H19N3O. CH4SO3
EXACT_MASS  377.1409
MOL_WEIGHT  377.4579
CLASS       Cardiovascular agent
             DG01466  Adrenergic receptor antagonist
              DG01465  alpha-Adrenergic receptor antagonist
             DG03231  Antihypertensive
REMARK      Therapeutic category: 2190 7290
            ATC code: C04AB01 V03AB36
            Chemical structure group: DG00280
            Product (DG00280): D00509<JP/US>
EFFICACY    Vasodilator, Diagnostic, alpha-Adrenergic receptor antagonist
COMMENT     Imidazoline derivative
TARGET      ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]
            ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]
  PATHWAY   hsa04080(146+147+148+150+151+152)  Neuroactive ligand-receptor interaction
            hsa04261(146+147+148)  Adrenergic signaling in cardiomyocytes
            hsa04270(146+147+148)  Vascular smooth muscle contraction
INTERACTION  
STR_MAP     map07215  alpha-Adrenergic receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C04 PERIPHERAL VASODILATORS
               C04A PERIPHERAL VASODILATORS
                C04AB Imidazoline derivatives
                 C04AB01 Phentolamine
                  D00509  Phentolamine mesylate (USP) &lt;JP/US&gt;
             V VARIOUS
              V03 ALL OTHER THERAPEUTIC PRODUCTS
               V03A ALL OTHER THERAPEUTIC PRODUCTS
                V03AB Antidotes
                 V03AB36 Phentolamine
                  D00509  Phentolamine mesylate (USP) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               219  Miscellaneous
                2190  Miscellaneous
                 D00509  Phentolamine mesylate (USP); Phentolamine mesilate (JAN/INN)
             7  Agents not mainly for therapeutic purpose
              72  Intracorporeal diagnostic agents
               729  Miscellaneous
                7290  Miscellaneous
                 D00509  Phentolamine mesylate (USP); Phentolamine mesilate (JAN/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01465  alpha-Adrenergic receptor antagonist
                DG00280  Phentolamine
                 D00509  Phentolamine mesylate
              DG03231  Antihypertensive
               DG00280  Phentolamine
                D00509  Phentolamine mesylate
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG03231  Antihypertensive
               D00509  Phentolamine mesylate
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA1
                 D00509  Phentolamine mesylate (USP) &lt;JP/US&gt;
                ADRA2
                 D00509  Phentolamine mesylate (USP) &lt;JP/US&gt;
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01465  alpha-Adrenergic receptor antagonist
                DG00280  Phentolamine
              DG03231  Antihypertensive
               DG00280  Phentolamine
DBLINKS     CAS: 65-28-1
            PubChem: 7847575
            ChEBI: 8081
            LigandBox: D00509
            NIKKAJI: J260.439F
ATOM        26
            1   N1c N    28.8633  -17.6079
            2   C8y C    30.0769  -18.3081
            3   C8y C    27.6555  -18.3081
            4   C1b C    28.8633  -16.2076
            5   C8x C    31.2905  -17.6079
            6   C8x C    30.0769  -19.7085
            7   C8x C    27.6555  -19.7142
            8   C8x C    26.4418  -17.6079
            9   C2y C    30.0769  -15.5133
            10  C8y C    32.5042  -18.3140
            11  C8x C    31.2847  -20.4087
            12  C8x C    26.4418  -20.4087
            13  C8x C    25.2282  -18.3081
            14  N1x N    31.4009  -15.9901
            15  N2x N    30.1298  -14.1132
            16  C8x C    32.5042  -19.7142
            17  O1a O    33.7120  -17.6079
            18  C8y C    25.2282  -19.7142
            19  C1x C    32.2542  -14.8896
            20  C1x C    31.4773  -13.7270
            21  C1a C    24.0145  -20.4144
            22  S4a S    38.8063  -17.5424
            23  C1a C    37.4103  -17.5353
            24  O1d O    40.2022  -17.5424
            25  O1d O    38.7992  -18.9384
            26  O1d O    38.7992  -16.1465
BOND        27
            1     2   5 1
            2     2   6 2
            3     3   7 1
            4     3   8 2
            5     4   9 1
            6     5  10 2
            7     6  11 1
            8     7  12 2
            9     8  13 1
            10    9  14 1
            11    9  15 2
            12   10  16 1
            13   10  17 1
            14   12  18 1
            15   14  19 1
            16   15  20 1
            17   18  21 1
            18   11  16 2
            19   13  18 2
            20   19  20 1
            21    1   2 1
            22    1   3 1
            23    1   4 1
            24   22  23 1
            25   22  24 1
            26   22  25 2
            27   22  26 2
///
